Meda Pharmaceuticals Inc.

FDA Regulatory Profile

Meda Pharmaceuticals Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 10 FDA inspections, and 1 compliance action on record. Its most recent recall (D-1418-2012, Class II) was initiated on October 17, 2011.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
10
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-1418-2012Class IIPrefera OB One Gel Capsules, 30 softgels, Rx Only, Manufactured by: IVC industries, Inc. Irving ton,October 17, 2011